The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure

被引:10
|
作者
Fu, Shihui [1 ,2 ,3 ]
Xie, Leixing [2 ,3 ]
Li, Dongyun [1 ,2 ,3 ]
Ye, Ping [1 ]
Luo, Leiming [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Beijing 100853, Peoples R China
关键词
NT-proBNP; prognosis; chronic heart failure; elderly; IMPACT; GUIDELINES; SURVIVAL;
D O I
10.2147/CIA.S77417
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: This study was conducted to research the prognostic utility of N-terminal pro-B-type natriuretic peptide (NT-proBNP), compare the utility of the Seattle Heart Failure Score (SHFS) with NT-proBNP, develop a risk-evaluation model based on NT-proBNP, assess the associations of NT-proBNP with patient characteristics, and screen for decisive factors of NT-proBNP in Chinese elderly with chronic heart failure (CHF). Patients and methods: There were 306 patients (>= 60 years) with CHF chosen as study subjects. Each one received an assessment of NT-proBNP on serum. The end point was all-cause mortality during a mean follow-up period of 471 days. Results: Subjects had a median age of 85 (60-100) years, a median NT-proBNP of 1,743.4 pg/mL, and a median SHFS of 1.87. During the follow-up period, 104 deaths occurred. NT-proBNP was significantly related to mortality (odds ratio 1.603, 95% confidence interval 1.407-1.826; P<0.001) and the significance persisted after full adjustment (odds ratio 1.282, 95% confidence interval 1.103-1.489; P=0.001). Age, New York Heart Association class IV CHF, plasma albumin, and neutrophils/lymphocytes were also independent predictors for mortality (P<0.05 for all). NT-proBNP and the SHFS showed similar predictive capacities (0.736 versus 0.796, P=0.105). The addition of NT-proBNP to the SHFS (0.818 versus 0.796, P=0.168) generated marginal growth in the c-statistic. The model based on NT-proBNP consisting of all selected predictors in this study, including age, New York Heart Association class IV CHF, plasma albumin, neutrophils/lymphocytes, and NT-proBNP, had a moderately higher c-statistic compared with the SHFS (0.846 versus 0.796, P=0.066). NT-proBNP was bound with the SHFS (r=0.500, P<0.001). Characteristics regarding general condition, inflammation, and cardiac and renal function were the decisive factors of NT-proBNP (P<0.05 for all). Conclusion: As a comprehensive representation of the patient characteristics described earlier, NT-proBNP values provided significant prognostic power similar to the SHFS in Chinese elderly with CHF. A novel model based on NT-proBNP could offer help for risk stratification.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [1] The role of N-terminal pro-B-type natriuretic peptide in prognostic evaluation of heart failure
    Lam, Carolyn S. P.
    Li, Yi-Heng
    Bayes-Genis, Antoni
    Ariyachaipanich, Aekarach
    Do Quang Huan
    Sato, Naoki
    Kahale, Pravin
    Ta Manh Cuong
    Dong, Yugang
    Li, Xinli
    Zhou, Yanli
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 447 - 451
  • [2] The value of repeated measurement of N-terminal pro-B-type natriuretic peptide for prognostic stratification in chronic heart failure
    Kubanek, M.
    Goode, K.
    Shaikh, A. Rab
    Hanning, I.
    Clark, A. L.
    Cleland, J. G. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 18 - 19
  • [3] Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
    Zile, Michael R.
    Claggett, Brian L.
    Prescott, Margaret F.
    McMurray, John J. V.
    Packer, Milton
    Rouleau, Jean L.
    Swedberg, Karl
    Desai, Akshay S.
    Gong, Jianjian
    Shi, Victor C.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (22) : 2425 - 2436
  • [4] N-Terminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
    Lainchbury, John G.
    Troughton, Richard W.
    Strangman, Kim M.
    Frampton, Christopher M.
    Pilbrow, Anna
    Yandle, Timothy G.
    Hamid, Amjad K.
    Nicholls, M. Gary
    Richards, A. Mark
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 55 (01) : 53 - 60
  • [5] N-terminal pro-B-type natriuretic peptide in the diagnosis of acute heart failure
    Lee, K. K.
    Doudesis, D.
    Anwar, M.
    Astengo, F.
    Japp, A.
    Tsanas, A.
    Shah, A. S., V
    Januzzi, J. L.
    Mills, N. L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1210 - 1210
  • [6] The relation between N-terminal pro-B-type natriuretic peptide and heart failure
    Balta, Sevket
    Demirkol, Sait
    Kucuk, Ugur
    Unlu, Murat
    Arslan, Zekeriya
    Celik, Turgay
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (10): : 1533 - 1533
  • [7] N-terminal pro-B-type natriuretic peptide levels in systolic heart failure
    Hamdi, I.
    Mahfoudhi, H.
    Ben Mansour, N.
    Mazni, F.
    Dahmani, R.
    Lahidheb, D.
    Fehri, W.
    Haouala, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 79 - 79
  • [8] Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease
    Zhang, Bin
    Xu, Haiyan
    Zhang, Haitong
    Liu, Qingrong
    Ye, Yunqing
    Hao, Jie
    Zhao, Qinghao
    Qi, Xiling
    Liu, Sisi
    Zhang, Erli
    Xu, Yujun
    Gao, Runlin
    Pibarot, Philippe
    Clavel, Marie-Annick
    Wu, Yongjian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (14) : 1659 - 1672
  • [9] Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure
    Hindertiter, Alan L.
    Blumenthal, James A.
    O'Conner, Christopher
    Adams, Kirkwood F.
    Dupree, Carla Sueta
    Waugh, Robert A.
    Bensimhon, Daniel
    Christenson, Robert H.
    Sherwood, Andrew
    AMERICAN HEART JOURNAL, 2008, 156 (06) : 1191 - 1195
  • [10] Cocoa flavanols reduce N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure
    De Palma, Rodney
    Sotto, Imelda
    Wood, Elizabeth G.
    Khan, Noorafza Q.
    Butler, Jane
    Johnston, Atholl
    Rothman, Martin T.
    Corder, Roger
    ESC HEART FAILURE, 2016, 3 (02): : 97 - 106